FR2114935A5 - - Google Patents

Info

Publication number
FR2114935A5
FR2114935A5 FR7141843A FR7141843A FR2114935A5 FR 2114935 A5 FR2114935 A5 FR 2114935A5 FR 7141843 A FR7141843 A FR 7141843A FR 7141843 A FR7141843 A FR 7141843A FR 2114935 A5 FR2114935 A5 FR 2114935A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7141843A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of FR2114935A5 publication Critical patent/FR2114935A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7141843A 1971-01-26 1971-11-23 Expired FR2114935A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10993371A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
FR2114935A5 true FR2114935A5 (en) 1972-06-30

Family

ID=22330355

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7141843A Expired FR2114935A5 (en) 1971-01-26 1971-11-23

Country Status (4)

Country Link
JP (1) JPS5417832B1 (en)
DE (1) DE2157693C3 (en)
FR (1) FR2114935A5 (en)
GB (1) GB1311268A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2208909A1 (en) * 1972-06-27 1974-06-28 Fujisawa Pharmaceutical Co

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU603343A3 (en) * 1972-11-13 1978-04-15 Эли Лилли Энд Компани (Фирма) Method of purifying c cephalosporin
FR2404642A1 (en) * 1977-09-29 1979-04-27 Roussel Uclaf NEW DERIVATIVE OF CEPHALOSPORIN C, PROCESS FOR PREPARATION AND APPLICATION OF THE NEW PRODUCT TO THE PREPARATION OF 7-AMINO CEPHALOSPORANIC ACID

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2208909A1 (en) * 1972-06-27 1974-06-28 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
DE2157693A1 (en) 1972-09-21
JPS5417832B1 (en) 1979-07-03
GB1311268A (en) 1973-03-28
DE2157693B2 (en) 1980-01-17
DE2157693C3 (en) 1980-09-11

Similar Documents

Publication Publication Date Title
ATA136472A (en)
AR196074A1 (en)
FR2114935A5 (en)
AU2691671A (en)
AU3005371A (en)
AU2684071A (en)
AU2742671A (en)
AU2894671A (en)
AU2941471A (en)
AU2952271A (en)
AR192311Q (en)
AR202997Q (en)
AU2684171A (en)
AU2927871A (en)
AU3025871A (en)
AU2963771A (en)
AU3038671A (en)
AU2706571A (en)
AU2399971A (en)
AU2940971A (en)
AU2938071A (en)
AU2930871A (en)
AU2724971A (en)
AU2907471A (en)
AU2726271A (en)

Legal Events

Date Code Title Description
ST Notification of lapse